secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-01-14T23:59:59+00:00
Accession:  0001193125-26-012028
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 3.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences raises $2.1M via exercise of options at reduced price; issues new options
--------------------------------------------------------------------------------

- Gross proceeds of approx. $2.1M from exercise of 808,595 existing options at reduced price of $2.575/share.
- Issued new unregistered options to purchase up to 1,617,190 shares at $2.325/share, expiring 30 months after resale registration effective date.
- Existing options originally exercisable at $9.00/share; induced exercise by lowering price to $2.575.
- Company to file resale registration statement for new option shares within 30 days of closing.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526012028/0001193125-26-012028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526012028/rkda-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-012028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer